rxstatShortages › Triamcinolone Acetonide Gramicidin Nystatin Neomycin

Triamcinolone Acetonide Gramicidin Nystatin Neomycin (Viaderm Kc) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Aug 17, 2026

Some Triamcinolone Acetonide Gramicidin Nystatin Neomycin products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 4, 2026.

A combination cream with a corticosteroid, antibiotics, and an antifungal used to treat inflamed, infected skin conditions.

Products affected
1 / 3
In shortage since
May 19, 2026
Est. full return
Sep 4, 2026
Reports on file
68
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
VIADERM KC CRM
1MG 0.25MG 100000UNIT 2.5MG · CREAM · TARO PHARMACEUTICALS INC
DIN 00717002 · since Jul 15, 2026, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
VIADERM KC CRM
1MG 0.25MG 100000UNIT 2.5MG · CREAM · TARO PHARMACEUTICALS INC
DIN 00717002 · since May 19, 2026, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Discontinued
VIADERM KC CRM
1MG 0.25MG 100000UNIT 2.5MG · CREAM · TARO PHARMACEUTICALS INC
DIN 00717002
Resolved
VIADERM KC ONT
100000UNIT 1MG 0.25MG 2.5MG · OINTMENT · TARO PHARMACEUTICALS INC
DIN 00717029 · ended Feb 11, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-TRIACOMB
0.25MG 2.5MG 1MG 100000UNIT · CREAM · TEVA CANADA LIMITED
DIN 00550507 · ended Dec 17, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-TRIACOMB
0.25MG 2.5MG 1MG 100000UNIT · CREAM · TEVA CANADA LIMITED
DIN 00550507 · ended Dec 17, 2025 · Disruption of the manufacture of the drug.
Resolved
VIADERM KC CRM
0.25MG 100000UNIT 1MG 2.5MG · CREAM · TARO PHARMACEUTICALS INC
DIN 00717002 · ended Nov 10, 2025 · Disruption of the manufacture of the drug.
Resolved
VIADERM KC CRM
0.25MG 100000UNIT 1MG 2.5MG · CREAM · TARO PHARMACEUTICALS INC
DIN 00717002 · ended Oct 14, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-TRIACOMB
0.25MG 2.5MG 100000UNIT 1MG · CREAM · TEVA CANADA LIMITED
DIN 00550507 · ended Jun 12, 2025 · Disruption of the manufacture of the drug.
Discontinued
TEVA-TRIACOMB
0.25MG 2.5MG 1MG 100000UNIT · CREAM · TEVA CANADA LIMITED
DIN 00550507
Resolved
VIADERM KC CRM
100000UNIT 0.25MG 2.5MG 1MG · CREAM · TARO PHARMACEUTICALS INC
DIN 00717002 · ended Feb 20, 2025 · Disruption of the manufacture of the drug.
Resolved
VIADERM KC CRM
100000UNIT 0.25MG 2.5MG 1MG · CREAM · TARO PHARMACEUTICALS INC
DIN 00717002 · ended Feb 20, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Triamcinolone Acetonide Gramicidin Nystatin Neomycin is currently affected by an active shortage report filed with Health Canada by TARO PHARMACEUTICALS INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Triamcinolone Acetonide Gramicidin Nystatin Neomycin is classified under “CORTICOSTEROIDS, COMB WITH ANTIBIOTICS” (ATC D07CB).

Recent changes

Common questions

What is Triamcinolone Acetonide Gramicidin Nystatin Neomycin used for?

A combination cream with a corticosteroid, antibiotics, and an antifungal used to treat inflamed, infected skin conditions.

When will Triamcinolone Acetonide Gramicidin Nystatin Neomycin be back in stock in Canada?

The latest manufacturer estimate is Sep 4, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Triamcinolone Acetonide Gramicidin Nystatin Neomycin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.